Spots Global Cancer Trial Database for desmoplastic small round cell tumor
Every month we try and update this database with for desmoplastic small round cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum | NCT04022213 | Desmoplastic Sm... Peritoneal Canc... Peritoneal Carc... | 131 I-omburtama... WAP-IMRT | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | NCT00043979 | Sarcoma | F-18 Fluorodeox... therapeutic all... cyclophosphamid... cyclosporine doxorubicin hyd... etoposide fludarabine pho... melphalan prednisone sirolimus tacrolimus vincristine sul... peripheral bloo... Filgrastim Peripheral Bloo... | 5 Years - 35 Years | National Institutes of Health Clinical Center (CC) | |
| Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma | NCT03478462 | Pediatric Solid... Pediatric Lymph... Pediatric Brain... DIPG Neuroblastoma Ewing Sarcoma Rhabdomyosarcom... Osteosarcoma | CLR 131 | 2 Years - 25 Years | Cellectar Biosciences, Inc. | |
| French National Registry of Rare Peritoneal Surface Malignancies | NCT02834169 | Rare Peritoneal... Pseudomyxoma Pe... Peritoneal Meso... Desmoplastic Sm... Psammocarcinoma Primary Periton... Diffuse Periton... Appendiceal Muc... | Non interventio... | - | Hospices Civils de Lyon | |
| MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma | NCT06277154 | Leiomyosarcoma Liposarcoma Synovial Sarcom... Angiosarcoma Undifferentiate... Epithelioid Sar... Malignant Perip... Fibrosarcoma Pleomorphic Rha... Endometrial Str... Desmoplastic Sm... | MASCT-I Doxorubicin Ifosfamide | 18 Years - 70 Years | HRYZ Biotech Co. | |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | NCT03600649 | Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum... | Seclidemstat Cyclophosphamid... Topotecan | 12 Years - | Salarius Pharmaceuticals, LLC | |
| CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor | NCT04145349 | Desmoplastic Sm... | Ramucirumab Cyclophosphamid... Vinorelbine | 12 Months - 29 Years | Eli Lilly and Company | |
| Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors | NCT04901806 | Solid Tumor, Ad... Brain Tumor, Pr... Desmoplastic Sm... | PBI-200 | 18 Years - | Pyramid Biosciences | |
| A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum | NCT04022213 | Desmoplastic Sm... Peritoneal Canc... Peritoneal Carc... | 131 I-omburtama... WAP-IMRT | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor | NCT01277744 | Advanced Cancer... Sarcoma | Hyperthermic Pe... Cisplatin | 1 Year - | M.D. Anderson Cancer Center | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor | NCT04145349 | Desmoplastic Sm... | Ramucirumab Cyclophosphamid... Vinorelbine | 12 Months - 29 Years | Eli Lilly and Company | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Lurbinectedin in FET-Fused Tumors | NCT05918640 | Ewing Sarcoma Desmoplastic Sm... Pediatric Cance... Undifferentiate... | Lurbinectedin | 10 Years - | Children's Hospital of Philadelphia | |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease | NCT01125449 | Sarcoma Adenocarcinoma Carcinoma Multiple Myelom... Desmoplastic Sm... | Ascorbic acid (... | 18 Years - | Situs Cancer Research Center | |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | NCT05266196 | Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit... | Seclidemstat | 12 Years - | Salarius Pharmaceuticals, LLC | |
| MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma | NCT06277154 | Leiomyosarcoma Liposarcoma Synovial Sarcom... Angiosarcoma Undifferentiate... Epithelioid Sar... Malignant Perip... Fibrosarcoma Pleomorphic Rha... Endometrial Str... Desmoplastic Sm... | MASCT-I Doxorubicin Ifosfamide | 18 Years - 70 Years | HRYZ Biotech Co. | |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults | NCT04483778 | Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma Melanoma | second generati... second generati... Pembrolizumab | 0 Years - 26 Years | Seattle Children's Hospital | |
| Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor | NCT04690374 | Desmoplastic Sm... | - | Memorial Sloan Kettering Cancer Center | ||
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease | NCT01125449 | Sarcoma Adenocarcinoma Carcinoma Multiple Myelom... Desmoplastic Sm... | Ascorbic acid (... | 18 Years - | Situs Cancer Research Center | |
| Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors | NCT04901806 | Solid Tumor, Ad... Brain Tumor, Pr... Desmoplastic Sm... | PBI-200 | 18 Years - | Pyramid Biosciences | |
| Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor | NCT01277744 | Advanced Cancer... Sarcoma | Hyperthermic Pe... Cisplatin | 1 Year - | M.D. Anderson Cancer Center | |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | NCT03600649 | Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum... | Seclidemstat Cyclophosphamid... Topotecan | 12 Years - | Salarius Pharmaceuticals, LLC | |
| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) | NCT04897321 | Pediatric Solid... Osteosarcoma Rhabdomyosarcom... Neuroblastoma Ewing Sarcoma Wilms Tumor Adrenocortical ... Desmoplastic Sm... Germ Cell Cance... Rhabdoid Tumor Clear Cell Sarc... Hepatoblastoma Melanoma Carcinoma Malignant Perip... Soft Tissue Sar... | Fludarabine Cyclophosphamid... MESNA B7-H3 CAR T cel... | - 21 Years | St. Jude Children's Research Hospital | |
| Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor | NCT04690374 | Desmoplastic Sm... | - | Memorial Sloan Kettering Cancer Center | ||
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | NCT05266196 | Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit... | Seclidemstat | 12 Years - | Salarius Pharmaceuticals, LLC | |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults | NCT03618381 | Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma | second generati... second generati... | 1 Year - 30 Years | Seattle Children's Hospital | |
| Lurbinectedin in FET-Fused Tumors | NCT05918640 | Ewing Sarcoma Desmoplastic Sm... Pediatric Cance... Undifferentiate... | Lurbinectedin | 10 Years - | Children's Hospital of Philadelphia | |
| Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | NCT00436657 | Peritoneal Neop... Retroperitoneal... Gastrointestina... Adenocarcinoma Neuroblastoma Ovarian Neoplas... Sarcoma Adrenocortical ... Wilms Tumor Rhabdomyosarcom... Desmoplastic Sm... | CHPP of Cisplat... Abdominal Surge... | 3 Years - 18 Years | M.D. Anderson Cancer Center | |
| Lurbinectedin in FET-Fused Tumors | NCT05918640 | Ewing Sarcoma Desmoplastic Sm... Pediatric Cance... Undifferentiate... | Lurbinectedin | 10 Years - | Children's Hospital of Philadelphia |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
